Switching to Interleukin-23 Inhibitors After Ineffectiveness of Ustekinumab: Evaluating Real-World Outcomes in Psoriasis Treatment Sarah E. ThomasMarieke M. B. SeygerJuul M. P. A. van den Reek Research Letter 27 May 2024
Correction to: Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program Brett KingJennifer SoungAlexandre Lejeune Correction Open access 24 May 2024
The Use of Biologic Agents for the Treatment of Cutaneous Immune-Related Adverse Events from Immune Checkpoint Inhibitors: A Review of Reported Cases Jolanta PachKailyn ValidoJonathan S. Leventhal Review Article 20 May 2024
Management and Long-Term Outcomes of Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS) in Children: A Scoping Review Nicole CherepachaFrances St George-HyslopRuud H. J. Verstegen Review Article 16 May 2024
Managing the Patient with Psoriasis and Metabolic Comorbidities Francesco BellinatoMartina MaurelliPaolo Gisondi Review Article Open access 15 May 2024
Approach to the Atypical Wound Sarah L. BeckerShannon KodyAlex G. Ortega-Loayza Review Article 14 May 2024
Dupilumab Safety and Efficacy up to 1 Year in Children Aged 6 Months to 5 Years with Atopic Dermatitis: Results from a Phase 3 Open-Label Extension Study Amy S. PallerElaine C. SiegfriedAshish Bansal Original Research Article Open access 14 May 2024
Efficacy, Safety, and Long-Term Disease Control of Ruxolitinib Cream Among Adolescents with Atopic Dermatitis: Pooled Results from Two Randomized Phase 3 Studies Lawrence F. EichenfieldEric L. SimpsonAmy S. Paller Original Research Article Open access 02 May 2024
American Academy of Dermatology Annual Meeting: San Diego, CA, USA, 8–12 March 2024 Kathy A. Fraser Meeting Report 26 April 2024 Pages: 509 - 512
Merkel Cell Carcinoma: Integrating Epidemiology, Immunology, and Therapeutic Updates Jürgen C. BeckerAndreas StangSelma Ugurel Review Article Open access 22 April 2024
Ultrasound Surveillance in Melanoma Management: Bridging Diagnostic Promise with Real-World Adherence: A Systematic Review and Meta-Analysis Zhao Feng LiuAmy SylivrisChristopher Chew Systematic Review 18 April 2024
Secondary Bacterial Infections in Patients with Atopic Dermatitis or Other Common Dermatoses Romain SallePascal Del GiudiceOlivier Chosidow Therapy in Practice 05 April 2024
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2) Jonathan I. SilverbergMelinda J. GooderhamDiamant Thaçi Original Research Article Open access 25 March 2024 Pages: 485 - 496
Tree-Based Machine Learning to Identify Predictors of Psoriasis Incidence at the Neighborhood Level: A Populational Study from Quebec, Canada Anastasiya MuntyanuRaymond MilanElena Netchiporouk Original Research Article 18 March 2024 Pages: 497 - 508
Expert Panel Review of Skin and Hair Dermatophytoses in an Era of Antifungal Resistance Rachel C. HillAvrom S. CaplanShari R. Lipner Review Article 18 March 2024 Pages: 359 - 389
Management of Acne in Pregnancy Akash RauJonette KeriJenny E. Murase Therapy in Practice 07 March 2024 Pages: 465 - 471
Small-Molecule Inhibitors and Biologics for Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review and Network Meta-Analysis I-Hsin HuangPo-Chien WuYu-Huei Huang Systematic Review 04 March 2024 Pages: 347 - 358
Rapidly Evolving Pre- and Post-surgical Systemic Treatment of Melanoma Ryan C. AugustinJason J. Luke Review Article 26 February 2024 Pages: 421 - 434
The Impact of Dermatologic Adverse Events on the Quality of Life of Oncology Patients: A Review of the Literature Annika BelzerJolanta J. PachJonathan S. Leventhal Review Article 16 February 2024 Pages: 435 - 445
Field Cancerization Therapies for the Management of Actinic Keratosis: An Updated Review Ishita AggarwalCarolina PuyanaMaria Tsoukas Review Article 13 February 2024 Pages: 391 - 405
Correction to: OX40 in the Pathogenesis of Atopic Dermatitis—A New Therapeutic Target Michael CroftEhsanollah EsfandiariEmma Guttman-Yassky Correction Open access 10 February 2024 Pages: 463 - 463
Autoimmune, Autoinflammatory Disease and Cutaneous Malignancy Associations with Hidradenitis Suppurativa: A Cross-Sectional Study Hilliard T. BrydgesOgechukwu C. OnuhErnest S. Chiu Original Research Article 09 February 2024 Pages: 473 - 484
Therapeutic Strategies in BRAF V600 Wild-Type Cutaneous Melanoma Alexandra HaughAdil I. Daud Review Article 08 February 2024 Pages: 407 - 419
Autoimmune and Cutaneous Inflammatory Comorbidities in Adult-Onset Morphea in the All of Us Research Program Jill T. ShahWilliam Mark RichardsonAlisa N. Femia Research Letter 02 February 2024 Pages: 343 - 345
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study Tiago TorresAndrea ChiricozziPaolo Gisondi Original Research Article Open access 24 January 2024 Pages: 333 - 342
Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program Brett KingJennifer SoungAlexandre Lejeune Original Research Article Open access 23 January 2024 Pages: 299 - 314
The Skin Microbiome and its Significance for Dermatologists Cleo WhitingSara Abdel AzimAdam Friedman Leading Article 22 January 2024 Pages: 169 - 177
Real-World Use of Ruxolitinib Cream: Safety Analysis at 1 Year Wilson HuMichele ThorntonRobert A. Livingston Original Research Article Open access 19 January 2024 Pages: 327 - 332
OX40 in the Pathogenesis of Atopic Dermatitis—A New Therapeutic Target Michael CroftEhsanollah EsfandiariEmma Guttman-Yassky Review Article Open access 18 January 2024 Pages: 447 - 461
Mucocutaneous Manifestations of Recreational Drug Use Carolina V. Alexander-SavinoGinat W. MirowskiDonna A. Culton Review Article 13 January 2024 Pages: 281 - 297
Targeted Systemic Therapies for Adults with Atopic Dermatitis: Selecting from Biologics and JAK Inhibitors Richard W. KimMegan LamAaron M. Drucker Review Article 12 January 2024 Pages: 179 - 193
Pressure and Skin: A Review of Disease Entities Driven or Influenced by Mechanical Pressure Wei-Chen ChienTsen-Fang Tsai Review Article 30 December 2023 Pages: 261 - 280
Pityriasis Rubra Pilaris: An Updated Review of Clinical Presentation, Etiopathogenesis, and Treatment Options Tejas P. JoshiMadeleine Duvic Review Article 30 December 2023 Pages: 243 - 259
Advancements in Bullous Pemphigoid Treatment: A Comprehensive Pipeline Update Meropi KarakioulakiKilian EyerichAikaterini Patsatsi Review Article Open access 29 December 2023 Pages: 195 - 212
Rare Autoinflammatory Neutrophilic Dermatoses in Pregnancy: Literature Review Angela LoBrittany ThompsonNaveed Sami Review Article 13 December 2023 Pages: 227 - 242
Recent Advances in Treatment of Systemic Sclerosis and Morphea Noelle TeskeNicole Fett Review Article 12 December 2023 Pages: 213 - 226
Treat-to-Target in Atopic Dermatitis Christian VestergaardCatalina SkovsgaardJacob P. Thyssen Review Article 11 December 2023 Pages: 91 - 98
Author Correction: Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study Tadashi TeruiYukari OkuboMasamoto Murakami Author Correction Open access 07 December 2023 Pages: 165 - 167
Review of Teledermatology: Lessons Learned from the COVID-19 Pandemic Jonathan K. HwangNatalia Pelet del ToroShari R. Lipner Leading Article 07 December 2023 Pages: 5 - 14
Photodynamic Therapy in Treating a Subset of Basal Cell Carcinoma: Strengths, Shortcomings, Comparisons with Surgical Modalities, and Potential Role as Adjunctive Therapy Maggie ChenAlbert ZhouAmor Khachemoune Review Article 02 December 2023 Pages: 99 - 118
Correction to: Assessment of Efficacy and Safety Outcomes Beyond Week 16 in Clinical Trials of Systemic Agents Used for the Treatment of Moderate to Severe Atopic Dermatitis in Combination with Topical Corticosteroids Jonathan I. SilverbergApril ArmstrongKristian Reich Correction Open access 27 November 2023 Pages: 163 - 163
What’s New in Cutaneous T-Cell Lymphoma-Associated Pruritus Georgia Biazus SoaresJoan GuitartGil Yosipovitch Review Article 16 November 2023 Pages: 67 - 77
Non-invasive Skin Imaging in Cutaneous Lymphomas Eyal TalebOriol YélamosShamir Geller Review Article 14 November 2023 Pages: 79 - 89
Correction to: AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History Luca StingeniAndrea ChiricozziAtopyReg® study group Correction Open access 07 November 2023 Pages: 161 - 161
Atopic Dermatitis: Fertility, Pregnancy, and Treatment Perspectives Mónica Munera-CamposJose Manuel Carrascosa Review Article 30 October 2023 Pages: 55 - 66
Tralokinumab Provides Clinically Meaningful Responses at Week 16 in Adults with Moderate-to-Severe Atopic Dermatitis Who Do Not Achieve IGA 0/1 Eric L. SimpsonAndrew BlauveltAndreas Wollenberg Original Research Article Open access 07 October 2023 Pages: 139 - 148
Guselkumab-Treated Patients with Plaque Psoriasis Who Achieved Complete Skin Clearance for ≥ 156 Consecutive Weeks: A Post-Hoc Analysis From the VOYAGE 1 Clinical Trial Luis PuigAntonio CostanzoCurdin Conrad Original Research Article Open access 07 October 2023 Pages: 315 - 325
AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History Luca StingeniAndrea ChiricozziAtopyReg® study group Original Research Article Open access 19 September 2023 Pages: 149 - 160
Chronic Prurigo Including Prurigo Nodularis: New Insights and Treatments Svenja MüllerClaudia ZeidlerSonja Ständer Review Article Open access 17 September 2023 Pages: 15 - 33